David Epstein

10.3k total citations · 1 hit paper
210 papers, 6.9k citations indexed

About

David Epstein is a scholar working on Surgery, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Epstein has authored 210 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Surgery, 43 papers in Economics and Econometrics and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Epstein's work include Health Systems, Economic Evaluations, Quality of Life (38 papers), Diagnosis and Treatment of Venous Diseases (19 papers) and Venous Thromboembolism Diagnosis and Management (12 papers). David Epstein is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (38 papers), Diagnosis and Treatment of Venous Diseases (19 papers) and Venous Thromboembolism Diagnosis and Management (12 papers). David Epstein collaborates with scholars based in Spain, United Kingdom and United States. David Epstein's co-authors include Mark Sculpher, Rita Faria, Ian R. White, Manuel Gomes, John D. Haley, Stuart Thomson, Janet T. Powell, Wallace T. Miller, Filippo Petti and Alun H. Davies and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David Epstein

195 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials

2014 388 citations David Epstein et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Epstein Spain	46	1.9k	1.4k	1.3k	1.0k	716	210	6.9k
Yi Qian United States	39	2.0k 1.0×	906 0.6×	851 0.7×	1.2k 1.2×	312 0.4×	197	6.5k
Mike Bradburn United Kingdom	40	799 0.4×	1.5k 1.0×	1.2k 1.0×	1.1k 1.1×	517 0.7×	164	8.1k
Issa J Dahabreh United States	43	848 0.4×	1.0k 0.7×	1.8k 1.4×	1.5k 1.5×	557 0.8×	155	7.3k
Yonggang Zhang China	37	2.2k 1.1×	1.4k 1.0×	746 0.6×	1.4k 1.4×	209 0.3×	350	8.5k
Ronald D. Barr Canada	66	1.2k 0.6×	1.1k 0.7×	1.3k 1.0×	3.1k 3.0×	1.5k 2.1×	387	15.8k
Nandita Mitra United States	55	1.0k 0.5×	2.0k 1.4×	2.2k 1.7×	2.0k 2.0×	865 1.2×	302	11.2k
Vivian Lee Hong Kong	43	1.2k 0.6×	1.1k 0.7×	599 0.5×	705 0.7×	225 0.3×	309	6.6k
Dong Ki Kim South Korea	49	1.8k 1.0×	1.6k 1.1×	1.4k 1.1×	662 0.7×	182 0.3×	507	9.6k
Cheng‐Chieh Lin Taiwan	54	2.9k 1.5×	1.4k 1.0×	1.1k 0.9×	1.3k 1.3×	259 0.4×	568	12.5k
Mousumi Banerjee United States	53	1.2k 0.6×	2.7k 1.9×	1.5k 1.2×	2.6k 2.6×	611 0.9×	247	10.6k

Countries citing papers authored by David Epstein

Since Specialization

Citations

This map shows the geographic impact of David Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Epstein more than expected).

Fields of papers citing papers by David Epstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Epstein. The network helps show where David Epstein may publish in the future.

Co-authorship network of co-authors of David Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of David Epstein. A scholar is included among the top collaborators of David Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Epstein. David Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Epstein, David. (2025). Pricing and reimbursement of off-patent medicines dispensed in community pharmacies. Gaceta Sanitaria. 39. 102506–102506.

Epstein, David, et al.. (2024). A Systematic Review of the Impact of Spinal Cord Injury on Costs and Health-Related Quality of Life. PharmacoEconomics - Open. 8(6). 793–808. 13 indexed citations

Burgess, Laura, Sasha Smith, Joseph Shalhoub, et al.. (2023). Neuromuscular electrical stimulation as an adjunct to standard care in improving walking distances in intermittent claudication patients: the NESIC RCT. SHILAP Revista de lepidopterología. 1–71.

Asingizwe, Domina, et al.. (2022). Evaluating the medical direct costs associated with prematurity during the initial hospitalization in Rwanda: a prevalence based cost of illness study. BMC Health Services Research. 22(1). 953–953. 3 indexed citations

Cordovilla‐Guardia, Sergio, et al.. (2020). Economic Analysis of Brief Motivational Intervention Following Trauma Related to Drugs and Alcohol. Nursing Research. 69(5). 358–366. 1 indexed citations

Yu, Jia, Nathan Harmston, Ron Smits, et al.. (2020). The Functional Landscape of Patient-Derived RNF43 Mutations Predicts Sensitivity to Wnt Inhibition. Cancer Research. 80(24). 5619–5632. 33 indexed citations

Wolfson, Theodore S., et al.. (2014). Outcomes of anterior cruciate ligament reconstruction in patients older than 50 years of age.. PubMed. 72(4). 277–83. 20 indexed citations

Richardson, Gerry, David Epstein, & Alison Wearden. (2012). PRM23 Cost-Effectiveness Versus Patient Acceptability: The Exemplar of CFS/ME. Value in Health. 15(7). A464–A464. 1 indexed citations

Rodgers, Mark, Marta Soares, David Epstein, et al.. (2011). Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer. Health Technology Assessment. 15(Suppl. 1). 1–12. 27 indexed citations

10.

Bhagwat, Shripad V., Prafulla C. Gokhale, Andrew P. Crew, et al.. (2011). Preclinical Characterization of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2: Distinct from Rapamycin. Molecular Cancer Therapeutics. 10(8). 1394–1406. 159 indexed citations

11.

Falcón, Beverly L., Sharon Barr, Prafulla C. Gokhale, et al.. (2011). Reduced VEGF Production, Angiogenesis, and Vascular Regrowth Contribute to the Antitumor Properties of Dual mTORC1/mTORC2 Inhibitors. Cancer Research. 71(5). 1573–1583. 80 indexed citations

12.

Buck, Elizabeth, Prafulla C. Gokhale, Susan Koujak, et al.. (2010). Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer. Molecular Cancer Therapeutics. 9(10). 2652–2664. 183 indexed citations

13.

Thomson, Stuart, et al.. (2008). Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy. Clinical & Experimental Metastasis. 25(8). 843–854. 156 indexed citations

14.

Buck, Elizabeth, Alexandra Eyzaguirre, Maryland Rosenfeld-Franklin, et al.. (2008). Feedback Mechanisms Promote Cooperativity for Small Molecule Inhibitors of Epidermal and Insulin-Like Growth Factor Receptors. Cancer Research. 68(20). 8322–8332. 164 indexed citations

15.

Burch, Jane, David Epstein, Helen Weatherly, et al.. (2008). Stapled haemorrhoidectomy (haemorrhoidopexy) for the treatment of haemorrhoids: a systematic review and economic evaluation. Health Technology Assessment. 12(8). iii–iv, ix. 60 indexed citations

16.

Grant, Adrian, Craig Ramsay, Laura Bojke, et al.. (2008). The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease – a UK collaborative study. The REFLUX trial. Health Technology Assessment. 12(31). 1–181, iii. 93 indexed citations

17.

Sennino, Barbara, Beverly L. Falcón, Dilara McCauley, et al.. (2007). Sequential Loss of Tumor Vessel Pericytes and Endothelial Cells after Inhibition of Platelet-Derived Growth Factor B by Selective Aptamer AX102. Cancer Research. 67(15). 7358–7367. 117 indexed citations

18.

Brown, Louise, David Epstein, Andrea Manca, et al.. (2004). The UK Endovascular Aneurysm Repair (EVAR) Trials: Design, Methodology and Progress. European Journal of Vascular and Endovascular Surgery. 27(4). 372–381. 96 indexed citations

19.

Rudolph, Johannes, David Epstein, L L Parker, & Jens Eckstein. (2001). Specificity of Natural and Artificial Substrates for Human Cdc25A. Analytical Biochemistry. 289(1). 43–51. 43 indexed citations

20.

Fenster, Laura, Gayle C. Windham, Shanna H. Swan, David Epstein, & Raymond Neutra. (1992). Tap or Bottled Water Consumption and Spontaneous Abortion in a Case-Control Study of Reporting Consistency. Epidemiology. 3(2). 120–124. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact